Butamax™ Advanced Biofuels LLC. Release: Court Orders Restraint on Gevo, Inc. Activity Pending Preliminary Injunction Decision
It is ordered that, until further order of the court, defendant Gevo, Inc., ... and those persons in active concert or participation with them who receive notice of the instant order by personal service or otherwise, shall not deliver, provide, distribute, ship, release, or transfer in any way bio-based isobutanol produced at Gevo's Luverne facility from recombinant yeast microorganisms to any third party for any use or purpose, except that it may sell its bio-based isobutanol produced at the Luverne facility to Sasol for chemical applications and the U.S. Air Force for jet fuel testing applications.
“This order provides protection for markets of key interest to Butamax,” said Paul Beckwith, Butamax CEO. “We are pleased the court took this urgent action and look forward to the Judge’s full preliminary injunction opinion.”
In 2003, BP and DuPont identified biobutanol as an ideal product to develop as an advanced biofuel. Research began in 2004 with the first patents being filed in 2005. Since that time, Butamax has built a comprehensive patent portfolio for the most cost-competitive biobutanol production technology.
Butamax™ Advanced Biofuels, LLC, a joint venture between BP and DuPont, was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont’s proven industrial biotechnology experience and BP’s global fuels market knowledge. Butamax’s proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information, visit www.butamax.com.